Precision BioSciences, Inc.
- DTIL
- NASDAQ
- Biotechnology
- Gene Editing (ARCUS)
- CAR T-Cell Therapy
- Clinical-Stage Biotech
$5.77
Today −6.48%Quote Oct 16, 2026, 08:00 PM UTC
−13.49%over the last month
Max drawdown −19.7%From 1-month high −19.7%3 months −21.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$159.3M
Quote Oct 16
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$20.00
+246.6% from here
Floor
$5.60
2.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DTILPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
67